We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Apoptosis and melanoma chemoresistance.
- Authors
Soengas, Maria S; Lowe, Scott W
- Abstract
Melanoma is the most aggressive form of skin cancer and is notoriously resistant to all current modalities of cancer therapy. A large set of genetic, functional and biochemical studies suggest that melanoma cells become 'bullet proof' against a variety of chemotherapeutic drugs by exploiting their intrinsic resistance to apoptosis and by reprogramming their proliferation and survival pathways during melanoma progression. In recent years, the identification of molecules involved in the regulation and execution of apoptosis, and their alteration in melanoma, have provided new insights into the molecular basis for melanoma chemoresistance. With this knowledge in hand, the challenge is now to devise strategies potent enough to compensate or bypass these cell death defects and improve the actual poor prognosis of patients at late stages of the disease.Oncogene (2003) 22, 3138-3151. doi:10.1038/sj.onc.1206454
- Subjects
MELANOMA; CELLS; CANCER treatment; CELL death; PATIENTS
- Publication
Oncogene, 2003, Vol 22, Issue 20, p3138
- ISSN
0950-9232
- Publication type
Article
- DOI
10.1038/sj.onc.1206454